Syntrix Illumina, Illumavista Settle Trademark Infringement Suit Premium Illumina has asked a federal court to dismiss a six-month-old trademark infringement lawsuit against Illumavista Biosciences following an apparent out-of-court settlement. Syntrix Will Use $115M in Illumina Royalties to Advance Biopharmaceutical Programs Premium While Syntrix Biosystems may have played a role in developing foundational microarray technology, the company does not intend to use a large, recently awarded royalty payment from Illumina to expand its presence in the array market. Jury Orders Illumina to Pay $96M for Infringing Syntrix's Array IP Premium This story was originally posted on March 15. Court Orders Illumina to Pay Syntrix $96M for Patent Infringement NEW YORK (GenomeWeb News) – A federal court jury has ordered Illumina to pay $96 million in damages to Syntrix Biosystems in a patent infringement case. Jury Trial Commences in Suit That Alleges Illumina's Array Products Violate Syntrix's IP Premium A jury is considering whether Illumina has infringed the intellectual property of Syntrix, a company with whom the San Diego vendor discussed a potential business relationship more than a decade ago. Feb 8, 2011 Illumina Denies Its Arrays Infringe Syntrix's IP, Asks Court to Dismiss Case Premium Nov 30, 2010 Syntrix Biosystems Sues Illumina for IP Infringement, Breach of Contract Premium Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.